Sort
25,944 grants matching “neurodegeneration”
Proteomics and biomarker
$196,456Rodney P Guttmann · University Of Kentucky · P01 · FY2009 · NS
Heterogeneity in toxicity of oligomeric amyloid beta and neuronal resilience in Alzheimer disease
$196,362Andrew Michael Stern · Brigham And Women'S Hospital · K08 · FY2022 · NS
Is S-adenosyl Methionine a Nutrition: Genetic Link in AD?
$196,350Thomas B Shea · University Of Massachusetts Lowell · R21 · FY2007 · AG
A Model for Olfactory Epithelial Neurodegeneration in Alzheimer's Disease
$196,350David M. Lin · Cornell University · R21 · FY2009 · AG
Adenosine A2A receptor cross-activation of TrkB in Huntington's disease
$196,250Donald C Lo · Duke University · R21 · FY2012 · NS
Novel strategies for glutamate clearance in a glia-deprived synaptic hub: Lessons from C. elegans
$196,250Itzhak Mano · City College Of New York · R21 · FY2016 · NS
The Role of Ubiquitin Phosphorylation in Cellular Aging
$196,250Jason A Macgurn · Vanderbilt University · R21 · FY2017 · AG
Development and characterization of an inducible model for myocilin POAG
$196,250Gulab Zode · University Of California-Irvine · R21 · FY2024 · EY
Whole brain multimodal microscopy of an apoptosis reporter mouse
$196,250Peter Jeff Nicholls · Duke University · R21 · FY2012 · NS
LRRK2 and mitochondrial dysfunction
$196,250Xiongwei Zhu · Case Western Reserve University · R21 · FY2010 · NS
Activation of Transcriptional Neuroprotective Programs in Nematode Excitotoxicity
$196,250Itzhak Mano · City College Of New York · R21 · FY2016 · NS
Exploring the mitochondrial function of TSEN in neuronal development and maintenance
$196,250Bingwei Lu · Stanford University · R21 · FY2017 · MH
Reversibility of brain glucose kinetics in type 2 diabetic subjects
$196,224Elizabeth Sanchez Rangel · Yale University · K23 · FY2023 · DK
QUANTITATIVE INDICES OF NEURON VULNERABILITY IN DEMENTIA
$196,218Mount Sinai School Of Medicine Of Cuny · P50 · FY2001 · AG
QUANTITATIVE INDICES OF NEURON VULNERABILITY IN DEMENTIA
$196,218Mount Sinai School Of Medicine Of Cuny · P50 · FY2002 · AG
The Role of Monocytes and Microglia in Traumatic Brain Injury-Induced Tauopathies
$196,143Bruce T Lamb · Cleveland Clinic Lerner Com-Cwru · R21 · FY2014 · NS
Glutaredoxin, a Critical Regulator of Parkinson Disease Pathogenesis
$196,143Shu G Chen · Case Western Reserve University · R21 · FY2014 · NS
CHANGING TAU PROTEIN LEVELS AND TAU PROTEIN ISOFORMS IN MOUSE MODELS OF DEMENTIA
$196,118Timothy M. Miller · Washington University · P50 · FY2012 · AG
GDNF AND BDNF EFFECTS ON AGE ISOLATED DOPAMINE NEURONS
$196,058Ann-Charlotte Esther Granholm-Bentley · Medical University Of South Carolina · P01 · FY2007 · AG
Somatic mutations in neurodevelopment and disease
$196,020Diane D Shao · Boston Children'S Hospital · K08 · FY2022 · NS
Leveraging myelin-sensitive imaging to predict early lesion pathogenesis in cerebral adrenoleukodystrophy
$196,020Eric Mallack · Weill Medical Coll Of Cornell Univ · K23 · FY2021 · NS
Development of a Translational Research Platform to Understand and treat Defective Protein Trafficking in Childhood-Onset Hereditary Spastic Paraplegia
$196,020Darius Ebrahimi-Fakhari · Boston Children'S Hospital · K08 · FY2021 · NS
Establishing Mechanisms Between Traumatic Brain Injury and Dementia Using Epidemiology, Clinical Studies, Blood-Based Biomarkers, and Neuroimaging Biomarkers
$196,020Andrea Lauren Christman Schneider · University Of Pennsylvania · K23 · FY2022 · NS
Development of a Translational Research Platform to Understand and treat Defective Protein Trafficking in Childhood-Onset Hereditary Spastic Paraplegia
$196,020Darius Ebrahimi-Fakhari · Boston Children'S Hospital · K08 · FY2022 · NS
a-KETOGLUTARATE DEHYDROGENASE IN NEURODEGENERATION
$196,004Winifred Masterson Burke Med Res Inst · P01 · FY2005 · AG